Clinical Trial Update: Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material [Phase 4]

View source ↗

Summary

This clinical trial update reports on the efficacy of faricimab in patients with age-related macular degeneration featuring subretinal hyper-reflective material…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Biobizkaia Health Research Institute | Conditions: Macular Degeneration, Age Related | Phase 4 | Status: NOT_YET_RECRUITING